SOPHARMA (SPH): Sales revenues for November 2018 - raport 142
Raport ESPI
UNI - EN REPORT No
142
/
2018
UNI - EN REPORT No142/2018
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for November 2018 the Company recorded a decrease of sales revenues of 9% compared to the same month of 2017, including 10% increase of domestic sales and a decrease of 23% of export sales.
